Topical formulation
AssigneeBomac Research Limited
InventorsKarthigeyan Nanjan, Fadil Al Alawi, Paul Chambers, Kate Hill
Life of this patent
Estimating the term…
Abstract
The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.
Claims24
A composition formulated for transdermal administration comprising at least one anti-hyperthyroid drug;
- at least one aprotic polar solvent;
- at least one polyo;
- and at least one fatty acid.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of treatment of hyperthyroidism in a non-human animal in need thereof comprising transdermal administration of a composition comprising at least one antihyperthyroid drug;
- at least one aprotic polar solvent;
- at least one polyol;
- and at least one fatty acid.
19-20. (canceled)
Use of a composition formulated for transdermal administration including at least one antihyperthyroid drug in the manufacture of a medicament for treatment of hyperthyroidism in an animal in need thereof;
- wherein the composition further comprises at least one aprotic polar solvent, at least one polyol and at least one fatty acid.
22-23. (canceled)
A method of manufacturing a composition formulated for transdermal administration comprising the steps of:
- (a) heating propylene glycol to a temperature of 50-60° C.;
- (b) dissolving PEG 4000 into the propylene glycol;
- (c) mixing in at least one compound selected from the group consisting of d-limonene, N-methyl-pyrrolidone, ethanol, triacetin, and combinations thereof;
- (d) dissolving in at least one antihyperthyroid drug;
- and
- (e) mixing in oleic acid and cooling.
25-28. (canceled)
Dependencies are inferred from the claim text.